Ignota Labs are proud to announce that we have appointed Didier Landais as an advisor and Non-Executive Director to the board.
Didier will bring his decades of international experience (including 17 years in the USA) as an executive across pharmaceutical and biotechnology companies.
In particular. Didier has a wealth of experience in-licensing and out-licensing drugs between biotechnology companies and pharm. His experience includes 4 years as the Global Head of Licensing (in and out) at Servier, Chief Executive Officer at 4P-Pharma, and Chief Operating Officer and Chief Business Officer at Lab Genius.
We are very excited to have Didier on board as we continue to grow and target asset acquisition and turnaround using our novel AI platform for drug safety.
